These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 33961399)
1. Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells. Ma Y; Mao G; Wu G; Chen M; Qin F; Zheng L; Zhang XE ACS Appl Mater Interfaces; 2021 Jun; 13(21):24477-24486. PubMed ID: 33961399 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells. Verma D; Church TM; Swaminathan S J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968 [TBL] [Abstract][Full Text] [Related]
3. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells. Chen J; Fan J; Chen Z; Zhang M; Peng H; Liu J; Ding L; Liu M; Zhao C; Zhao P; Zhang S; Zhang X; Xu J Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873039 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. Edwards MJ; Becker KA; Gripp B; Hoffmann M; Keitsch S; Wilker B; Soddemann M; Gulbins A; Carpinteiro E; Patel SH; Wilson GC; Pöhlmann S; Walter S; Fassbender K; Ahmad SA; Carpinteiro A; Gulbins E J Biol Chem; 2020 Nov; 295(45):15174-15182. PubMed ID: 32917722 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells. Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572 [TBL] [Abstract][Full Text] [Related]
6. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
7. Equine bronchial epithelial cells are susceptible to cell entry with a SARS-CoV-2 pseudovirus but reveal low replication efficiency. Legere RM; Allegro AR; Affram Y; Silveira BPD; Fridley JL; Wells KM; Oezguen N; Burghardt RC; Wright GA; Pollet J; Bordin AI; Figueiredo P; Leibowitz JL; Cohen ND Am J Vet Res; 2023 Sep; 84(9):. PubMed ID: 37442546 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems. Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210 [TBL] [Abstract][Full Text] [Related]
9. Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2. Chang YS; Chu LW; Chen ZY; Wu JS; Su WC; Yang CJ; Ping YH; Lin CW Viruses; 2022 Dec; 14(12):. PubMed ID: 36560829 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. Bayati A; Kumar R; Francis V; McPherson PS J Biol Chem; 2021; 296():100306. PubMed ID: 33476648 [TBL] [Abstract][Full Text] [Related]
11. An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research. Yang P; Yang Y; Wu Y; Huang C; Ding Y; Wang X; Wang S J Virol Methods; 2021 Sep; 295():114221. PubMed ID: 34182038 [TBL] [Abstract][Full Text] [Related]
12. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms. Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL Viruses; 2021 May; 13(6):. PubMed ID: 34064066 [TBL] [Abstract][Full Text] [Related]
13. Repositioning of histamine H Ge S; Wang X; Hou Y; Lv Y; Wang C; He H Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607 [TBL] [Abstract][Full Text] [Related]
14. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV. Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling. Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS Cells; 2021 Jul; 10(7):. PubMed ID: 34359983 [TBL] [Abstract][Full Text] [Related]
16. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669 [TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2). Xiang Y; Wang M; Chen H; Chen L Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003 [TBL] [Abstract][Full Text] [Related]
18. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells. Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289 [TBL] [Abstract][Full Text] [Related]
19. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Ou X; Liu Y; Lei X; Li P; Mi D; Ren L; Guo L; Guo R; Chen T; Hu J; Xiang Z; Mu Z; Chen X; Chen J; Hu K; Jin Q; Wang J; Qian Z Nat Commun; 2020 Mar; 11(1):1620. PubMed ID: 32221306 [TBL] [Abstract][Full Text] [Related]
20. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells. Amraei R; Xia C; Olejnik J; White MR; Napoleon MA; Lotfollahzadeh S; Hauser BM; Schmidt AG; Chitalia V; Mühlberger E; Costello CE; Rahimi N Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35078919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]